These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 16152763)

  • 21. Effect of an induction period of pegylated interferon-α2a and ribavirin on early virological response in HIV-HCV-coinfected patients: results from the CORAL-2 study.
    Tural C; Solà R; Alvarez NP; Moltó J; Sánchez M; Zamora AM; Ornelas A; Laguno M; González J; von Wichmann MÁ; Téllez MJ; Paredes R; Clotet B;
    Antivir Ther; 2011; 16(6):833-41. PubMed ID: 21900715
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV and hepatitis C co-infection: acute HCV therapy.
    Boesecke C; Vogel M
    Curr Opin HIV AIDS; 2011 Nov; 6(6):459-64. PubMed ID: 22001891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical trials of treatment for hepatitis C virus infection in HIV-infected patients: past, present, and future.
    Shire NJ; Sherman KE
    Clin Infect Dis; 2005 Jul; 41 Suppl 1():S63-8. PubMed ID: 16265616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of hepatitis C in HIV/hepatitis C co-infected patients: what is the evidence?
    Cacoub P
    Int J STD AIDS; 2005 Jan; 16(1):1-4. PubMed ID: 15705263
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin resistance and HCV virologic response to peg-interferons (Peg-IFN) with ribavirin (RBV) in HIV/HCV co-infected patients.
    Donato C; Cingolani A; Pinnetti C; De Luca A
    J Hepatol; 2010 Feb; 52(2):306-7. PubMed ID: 20006404
    [No Abstract]   [Full Text] [Related]  

  • 26. Study results presented on interferon/ribavirin combination therapy.
    AIDS Read; 2001 Aug; 11(8):398. PubMed ID: 11570262
    [No Abstract]   [Full Text] [Related]  

  • 27. [Peginterferon-alfa-2b or -alfa-2a and ribavirin combined treatment in hepatitis C infection].
    Szalay F
    Orv Hetil; 2010 Feb; 151(7):271-3. PubMed ID: 20133247
    [No Abstract]   [Full Text] [Related]  

  • 28. Acquired factor VIII inhibitor in an HIV-infected patient after treatment with pegylated interferon-alpha 2a and ribavirin.
    Paul S; Javed U; Tevendale R; Lanford J; Liu R
    AIDS; 2007 Mar; 21(6):784-5. PubMed ID: 17413709
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of acute HCV infection in HIV-positive patients: experience from a multicentre European cohort.
    Vogel M; Dominguez S; Bhagani S; Azwa A; Page E; Guiguet M; Valantin MA; Katlama C; Rockstroh JK; Nelson M
    Antivir Ther; 2010; 15(2):267-79. PubMed ID: 20386082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of early treatment of acute hepatitis C infection with pegylated interferon and ribavirin in HIV-infected patients.
    Dominguez S; Ghosn J; Valantin MA; Schruniger A; Simon A; Bonnard P; Caumes E; Pialoux G; Benhamou Y; Thibault V; Katlama C
    AIDS; 2006 May; 20(8):1157-61. PubMed ID: 16691067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hepatitis C and HIV coinfection. Current aspects of therapy].
    Rockstroh JK
    MMW Fortschr Med; 2002 Apr; 144 Suppl 1():30-2. PubMed ID: 12043070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sexually transmitted reinfection with a new hepatitis C genotype during pegylated interferon and ribavirin therapy.
    den Hollander JG; Rijnders BJ; van Doornum GJ; van der Ende ME
    AIDS; 2005 Mar; 19(6):639-40. PubMed ID: 15802989
    [No Abstract]   [Full Text] [Related]  

  • 33. [Efficacy and safety of pegylated-interferon plus ribavirin in HIV-infected patients co-infected with hepatitis C virus in clinical practice: a 32 cases observational follow-up].
    Seydi M; Morlat P; Bonnet F; Rambeloarisoa J; Bernard N; Lacoste D; Bonarek M; Trimoulet P; Ramanampamonjy R; Lafon ME; Dramé M; Beylot J
    Rev Med Interne; 2005 Apr; 26(4):280-7. PubMed ID: 15820563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV & hepatitis C: treatment.
    WORLD; 2002 May; (133):4-5. PubMed ID: 12064298
    [No Abstract]   [Full Text] [Related]  

  • 35. HCV infection in the setting of HIV: prevalence, disease, treatment.
    Laurence J
    AIDS Read; 2006 Mar; 16(3):115-6. PubMed ID: 16538952
    [No Abstract]   [Full Text] [Related]  

  • 36. Distinct hepatitis C virus kinetics in HIV-infected patients treated with ribavirin plus either pegylated interferon alpha2a or alpha2b.
    Vispo E; Barreiro P; Rodriguez-Nóvoa S; Morello J; Labarga P; Martín-Carbonero L; Maida I; García-Gascó P; Soriano V
    Antivir Ther; 2008; 13(4):511-7. PubMed ID: 18672529
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of concomitant antiretroviral therapy on the rate of sustained virological response to pegylated interferon plus ribavirin in hepatitis C virus/HIV-coinfected patients.
    Pineda JA; Mira JA; Gil Ide L; Valera-Bestard B; Rivero A; Merino D; Girón-González JA; Ríos-Villegas MJ; González-Serrano M; Collado A; García-García JA; Carrillo-Gómez R; López-Cortés LF; Gómez-Mateos J
    J Antimicrob Chemother; 2007 Dec; 60(6):1347-54. PubMed ID: 17938129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differences in virological response to pegylated interferon and ribavirin between hepatitis C virus (HCV)-monoinfected and HCV-HIV-coinfected patients.
    Tural C; Galeras JA; Planas R; Coll S; Sirera G; Giménez D; Salas A; Rey-Joly C; Cirera I; Márquez C; Tor J; Videla S; García-Retortillo M; Clotet B; Solà R
    Antivir Ther; 2008; 13(8):1047-55. PubMed ID: 19195330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Co-infections. German doctors treat hepatitis C early, with some success.
    TreatmentUpdate; 2006; 18(5):3-4. PubMed ID: 17209229
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment algorithm for the management of hepatitis C in HIV-coinfected persons.
    Sulkowski MS
    J Hepatol; 2006; 44(1 Suppl):S49-55. PubMed ID: 16360232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.